Summary
This prediction ended on 10.01.11 with a price of €15.43. With a performance of -7.39%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| QIAGEN NV | - | - | - | - |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% | 59.636% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% | 82.446% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% | 59.334% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% | 55.648% |
According to melinda what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread QIAGEN NV diskutieren
Biotechnologie
QIAGEN Marktführer in manuellen und automatisierten Aufreinigung von Nukleinsäuren ACDE Life-Science-Produkten für den Nachweis menschlicher Krankheitserreger
(Laufzeit überschritten)